mirtazapine + bupivacaine + morphine

This is a combination of three drugs—mirtazapine, bupivacaine, and morphine—used together primarily in the context of perioperative or postoperative pain management. - **Mirtazapine** is a tetracyclic antidepressant that acts as an antagonist at central presynaptic alpha-2 adrenergic inhibitory autoreceptors and heteroreceptors, increasing noradrenergic and serotonergic activity. It also blocks 5-HT2 and 5-HT3 serotonin receptors, which may contribute to its antipruritic effects when used with neuraxial opioids[3][4][7]. - **Bupivacaine** is a long-acting local anesthetic that blocks voltage-gated sodium channels in neuronal membranes, inhibiting nerve impulse conduction to provide regional anesthesia[4][5]. - **Morphine** is an opioid analgesic that acts primarily as an agonist at the mu-opioid receptor in the central nervous system to produce analgesia. When administered intrathecally or epidurally with local anesthetics like bupivacaine, it provides prolonged pain relief but can cause side effects such as pruritus[4][5]. The combination of these agents leverages their complementary mechanisms for enhanced postoperative analgesia while potentially reducing opioid-induced side effects such as pruritus through mirtazapine’s serotonergic antagonism[1][7].